Cost-Effectiveness of Treatment of Childhood Acute Lymphoblastic Leukemia With Chemotherapy Only: The Influence of New Medication and Diagnostic Technology

Research output: Contribution to journalArticleAcademicpeer-review

Original languageUndefined/Unknown
Pages (from-to)1005-1010
JournalPediatric Blood and Cancer
Volume57
Issue number6
DOIs
Publication statusPublished - 2011

Cite this

@article{be220f1d5c07443ba2104127aa63c0db,
title = "Cost-Effectiveness of Treatment of Childhood Acute Lymphoblastic Leukemia With Chemotherapy Only: The Influence of New Medication and Diagnostic Technology",
author = "{van Litsenburg}, R.R.L. and {Uyl-de Groot}, C.A. and H. Raat and G.J.L. Kaspers and R.J.B.J. Gemke",
year = "2011",
doi = "10.1002/pbc.23197",
language = "Undefined/Unknown",
volume = "57",
pages = "1005--1010",
journal = "Pediatric Blood and Cancer",
issn = "1545-5009",
publisher = "Wiley-Liss Inc.",
number = "6",

}

TY - JOUR

T1 - Cost-Effectiveness of Treatment of Childhood Acute Lymphoblastic Leukemia With Chemotherapy Only: The Influence of New Medication and Diagnostic Technology

AU - van Litsenburg, R.R.L.

AU - Uyl-de Groot, C.A.

AU - Raat, H.

AU - Kaspers, G.J.L.

AU - Gemke, R.J.B.J.

PY - 2011

Y1 - 2011

U2 - 10.1002/pbc.23197

DO - 10.1002/pbc.23197

M3 - Article

VL - 57

SP - 1005

EP - 1010

JO - Pediatric Blood and Cancer

JF - Pediatric Blood and Cancer

SN - 1545-5009

IS - 6

ER -